文献速递新生儿儿童心血管与肾脏

2006至2015年美国新生儿重症监护病房动脉导管未闭诊断与治疗的变化

Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units.
PubMed 文献 · J Pediatr · 2017-06-07

该研究基于美国280个NICU的临床数据仓库,纳入2006至2015年出生的61 520例23至30周无主要畸形的早产儿,分析动脉导管未闭(PDA)诊断、药物治疗及手术结扎的变化。结果显示PDA诊断率从51%降至38%,吲哚美辛或布洛芬使用率从32%降至18%,PDA结扎率从8.4%降至2.9%(均P < .001),期间死亡率下降且未观察到所测 morbidity 增加。结论认为PDA诊断和治疗显著减少,但这些变化对婴儿结局的直接影响尚不确定。

要点

  • 2006至2015年间美国NICU早产儿PDA诊断率从51%降至38%,药物治疗从32%降至18%,结扎从8.4%降至2.9%。
  • 研究期间死亡率下降,且未观察到任何所测 morbidity 增加。
  • 多数中心(79%–83%)在2011–2015年较2006–2010年呈现PDA诊断、药物治疗或结扎的下降。

核心结论

  • 在美国280个NICU的<30周早产儿中,PDA的诊断、药物治疗和手术结扎均显著减少,死亡率下降且未测到 morbidity 增加,但这些变化对婴儿结局的直接作用仍不确定。

研究设计与样本

  • 回顾性队列研究,查询Pediatrix临床数据仓库,纳入2006至2015年出生、23至30周胎龄、无主要畸形的61 520例婴儿,来自280个NICU。

主要发现

  • PDA诊断率从51%降至38%(P < .001),吲哚美辛或布洛芬使用率从32%降至18%(P < .001),PDA结扎率从8.4%降至2.9%(P < .001)。
  • 研究期间死亡率下降,且未观察到任何所测 morbidity 增加。
  • 在163个有 both periods 数据的中心中,128个(79%)PDA诊断下降,132个(81%)吲哚美辛和/或布洛芬使用下降(2011–2015 vs 2006–2010)。
  • 在103个至少有过1例PDA结扎的中心中,85个(83%)结扎下降(2011–2015 vs 2006–2010)。

临床怎么用

  • 临床可参考该趋势:对23–30周早产儿PDA的诊断和干预趋于减少,但需个体化评估,因研究未证明减少干预直接改善或恶化结局。

局限性

  • 原文未明确报告局限性;研究为观察性数据仓库分析,无法确定PDA诊断和治疗变化与婴儿结局之间的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify changes in the diagnosis, pharmacotherapy, and surgical ligation of patent ductus arteriosus (PDAs) in infants born premature and report on temporal changes in mortality and morbidity from a large volume of neonatal intensive care units (NICUs) in the US. STUDY DESIGN: We queried the Pediatrix Clinical Data Warehouse for all inborn infants without major anomalies born between 23 and 30 weeks' gestation from 2006 to 2015 for a diagnosis of PDA, use of indomethacin or ibuprofen, history of ductal ligation, mortality, and major morbidities. RESULTS: There were 829 091 infants entered in the Clinical Data Warehouse; 61 520 infants from 280 NICUs met our inclusion criteria. The diagnosis of PDA declined from 51% to 38% (P < .001), use of indomethacin or ibuprofen decreased from 32% to 18%, and PDA ligation decreased from 8.4% to 2.9% (both P < .001). During the study period, mortality decreased with no increase in any measured morbidity. Of the 163 sites with data for both periods, 128 (79%) showed a decrease in the diagnosis of PDA, and 132 (81%) showed a decrease in the use indomethacin and/or ibuprofen when 2011-2015 was compared with 2006-2010. Of 103 sites with at least 1 PDA ligation, 85 (83%) showed a decrease in PDA ligation in a similar comparison. CONCLUSIONS: In this large population of infants <30 weeks' gestation from 280 NICUs across the US, there were significant decreases in the diagnosis and treatment of the PDA. Although there was no evidence of increased morbidities, it remains uncertain how these changes may directly affect infant outcomes.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Bixler GM, Powers GC, Clark RH, et al. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. J Pediatr. 2017. PMID: 28600155. doi:10.1016/j.jpeds.2017.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。